Back to Journals » Journal of Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma


Journal Articles:

- 279 records -

Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study

Ruan SM, Cheng MQ, Huang H, Hu HT, Li W, Xie XY, Lu MD, Kuang M, Lin MX, Wang W

Journal of Hepatocellular Carcinoma 2022, 9:437-451

Published Date: 20 May 2022

RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma

Zhang L, Zhang Y, Shen D, Chen Y, Feng J, Wang X, Ma L, Liao Y, Tang L

Journal of Hepatocellular Carcinoma 2022, 9:405-422

Published Date: 9 May 2022

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology

Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, Wang Y, Yuan X, Cui L, Zhang Y, Zhao S, Li W, Wang Y, Sun X, Liu L, Dong S, Li L, Zhao W, Nan Y

Journal of Hepatocellular Carcinoma 2022, 9:389-403

Published Date: 9 May 2022

Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?

Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P

Journal of Hepatocellular Carcinoma 2022, 9:379-387

Published Date: 5 May 2022

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation

Guo Y, Ren Y, Dong X, Kan X, Zheng C

Journal of Hepatocellular Carcinoma 2022, 9:343-355

Published Date: 26 April 2022

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients

Hu Z, Sun X, Mei J, Hu Z, Yang Z, Hou J, Fu Y, Wang X, Chen M

Journal of Hepatocellular Carcinoma 2022, 9:315-325

Published Date: 19 April 2022

Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B

Hsueh RC, Wu WJ, Lin CL, Liu CJ, Huang YW, Hu JT, Wu CF, Sung FY, Liu WJ, Yu MW

Journal of Hepatocellular Carcinoma 2022, 9:301-313

Published Date: 11 April 2022

MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene

Niu Z, Yang F, Li H, Wang J, Ni Q, Ma C, Zhu H, Chang H, Zhou X, Lu J, Gao H

Journal of Hepatocellular Carcinoma 2022, 9:289-300

Published Date: 8 April 2022

Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer

Ren P, Wang K, Ma J, Cao X, Zhao J, Zhao C, Guo Y, Ye H

Journal of Hepatocellular Carcinoma 2022, 9:221-232

Published Date: 29 March 2022

LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment

Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y

Journal of Hepatocellular Carcinoma 2022, 9:203-220

Published Date: 22 March 2022

Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma

Xu T, Ren L, Liao M, Zhao B, Wei R, Zhou Z, He Y, Zhang H, Chen D, Chen H, Liao W

Journal of Hepatocellular Carcinoma 2022, 9:189-201

Published Date: 20 March 2022

Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma

Chen B, Gu Y, Shen H, Liu Q, Wang H, Li Y, Liu X, Liu Y, Du Q, Sun H, Liao X

Journal of Hepatocellular Carcinoma 2022, 9:171-188

Published Date: 11 March 2022

Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study

Huang J, Guo Y, Huang W, Hong X, Quan Y, Lin L, Zhou J, Liang L, Zhang Y, Zhou J, Cai M, Zhu K

Journal of Hepatocellular Carcinoma 2022, 9:157-170

Published Date: 10 March 2022

The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma

Wu Z, Cheng H, Liu J, Zhang S, Zhang M, Liu F, Li Y, Huang Q, Jiang Y, Chen S, Lv L, Li D, Zeng JZ

Journal of Hepatocellular Carcinoma 2022, 9:141-155

Published Date: 8 March 2022

Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study

Lin K, Wei F, Huang Q, Lai Z, Zhang J, Chen Q, Jiang Y, Kong J, Tang S, Lin J, Chen Y, Chen J, Zeng Y

Journal of Hepatocellular Carcinoma 2022, 9:127-140

Published Date: 8 March 2022

MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met

Xu X, Jiang W, Han P, Zhang J, Tong L, Sun X

Journal of Hepatocellular Carcinoma 2022, 9:113-126

Published Date: 27 February 2022

Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma

Xue D, Han J, Liang Z, Jia L, Liu Y, Tuo H, Peng Y

Journal of Hepatocellular Carcinoma 2022, 9:99-112

Published Date: 18 February 2022

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression

Ma X, Zhuang H, Wang Q, Yang L, Xie Z, Zhang Z, Tan W, Tang C, Chen Y, Shang C

Journal of Hepatocellular Carcinoma 2022, 9:83-98

Published Date: 15 February 2022

Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning Approach

Thomas J, Liao LM, Sinha R, Patel T, Antwi SO

Journal of Hepatocellular Carcinoma 2022, 9:69-81

Published Date: 15 February 2022

CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma

Zhang X, Wang X, Jia L, Yang Y, Yang F, Xiao S

Journal of Hepatocellular Carcinoma 2022, 9:57-67

Published Date: 11 February 2022

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma

Li Y, Li Y, Zhang J, Ji L, Li M, Sun X, Feng H, Yu Z, Gao Y

Journal of Hepatocellular Carcinoma 2022, 9:41-56

Published Date: 9 February 2022

Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival

Young S, Ragulojan R, Chen T, Owen J, D'souza D, Sanghvi T, Golzarian J, Flanagan S

Journal of Hepatocellular Carcinoma 2022, 9:29-39

Published Date: 4 February 2022

Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program

Turse E, Aboona M, Charley E, Forlemu A, Bowie T, Bhattarai B, Chuang KY, Nadir A

Journal of Hepatocellular Carcinoma 2022, 9:1-11

Published Date: 22 January 2022

Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway

Wang C, Lv Y, Sha Z, Zhang J, Wu J, Qi Y, Guo Z

Journal of Hepatocellular Carcinoma 2021, 8:1643-1653

Published Date: 29 December 2021

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma

Deng Z, Huang K, Liu D, Luo N, Liu T, Han L, Du D, Lian D, Zhong Z, Peng J

Journal of Hepatocellular Carcinoma 2021, 8:1607-1622

Published Date: 18 December 2021

Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007–2018

Shankaran V, Chennupati S, Sanchez H, Sun Q, Li L, Fedorenko C, Aly A, Healey M, Seal B

Journal of Hepatocellular Carcinoma 2021, 8:1597-1606

Published Date: 14 December 2021

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis

Aydin Y, Koksal AR, Thevenot P, Chava S, Heidari Z, Lin D, Sandow T, Moroz K, Parsi MA, Scott J, Cohen A, Dash S

Journal of Hepatocellular Carcinoma 2021, 8:1579-1596

Published Date: 8 December 2021

Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study

Kim MA, Jang H, Choi NR, Nam JY, Lee YB, Cho EJ, Lee JH, Yu SJ, Kim HC, Chung JW, Yoon JH, Kim YJ

Journal of Hepatocellular Carcinoma 2021, 8:1565-1577

Published Date: 7 December 2021

Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver

Feng J, Zhu R, Yin Y, Wang S, Zhou L, Lv F, Zhao D

Journal of Hepatocellular Carcinoma 2021, 8:1537-1563

Published Date: 7 December 2021

Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization

Li T, Shi Q, Liu J, Wang Y, Zhou C, Wang C, Ju S, Huang S, Yang C, Chen Y, Bai Y, Xiong B

Journal of Hepatocellular Carcinoma 2021, 8:1525-1535

Published Date: 3 December 2021

Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort

Young S, Cam I, Gencturk M, Rubin N, D'souza D, Flanagan S, Golzarian J, Sanghvi T

Journal of Hepatocellular Carcinoma 2021, 8:1513-1524

Published Date: 1 December 2021

PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration

Liu X, Zhang Y, Wang Z, Liu L, Zhang G, Li J, Ren Z, Dong Z, Yu Z

Journal of Hepatocellular Carcinoma 2021, 8:1495-1511

Published Date: 1 December 2021

Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib

Pomej K, Balcar L, Scheiner B, Semmler G, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M

Journal of Hepatocellular Carcinoma 2021, 8:1485-1493

Published Date: 30 November 2021

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma

Huang J, Huang W, Zhan M, Guo Y, Liang L, Cai M, Lin L, He M, Lian H, Lu L, Zhu K

Journal of Hepatocellular Carcinoma 2021, 8:1445-1458

Published Date: 26 November 2021

Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways

Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A, Sethi G

Journal of Hepatocellular Carcinoma 2021, 8:1415-1444

Published Date: 25 November 2021

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC

De Battista D, Zamboni F, Gerstein H, Sato S, Markowitz TE, Lack J, Engle RE, Farci P

Journal of Hepatocellular Carcinoma 2021, 8:1399-1413

Published Date: 21 November 2021

Role of Rab GTPases in Hepatocellular Carcinoma

Yang CC, Meng GX, Dong ZR, Li T

Journal of Hepatocellular Carcinoma 2021, 8:1389-1397

Published Date: 19 November 2021

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma

Han Q, Deng H, Fan X, Wang X, Zhang X, Zhang K, Li N, Lv Y, Liu Z

Journal of Hepatocellular Carcinoma 2021, 8:1367-1373

Published Date: 13 November 2021

CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis

Zhou X, Li TM, Luo JZ, Lan CL, Wei ZL, Fu TH, Liao XW, Zhu GZ, Ye XP, Peng T

Journal of Hepatocellular Carcinoma 2021, 8:1323-1338

Published Date: 3 November 2021

Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma

Hsiang CW, Huang WY, Yang JF, Shen PC, Dai YH, Wang YF, Lin CS, Chang WC, Lo CH

Journal of Hepatocellular Carcinoma 2021, 8:1299-1309

Published Date: 29 October 2021

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection [Corrigendum]

Ji GW, Fan Y, Sun DW, Wu MY, Wang K, Li XC, Wang XH

Journal of Hepatocellular Carcinoma 2021, 8:1297-1298

Published Date: 27 October 2021

Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels

Cheng J, Li Y, Wang X, Dong Z, Chen Y, Zhang R, Huang J, Jin X, Yao J, Ge A, Song L, Lu Y, Zeng Z

Journal of Hepatocellular Carcinoma 2021, 8:1281-1295

Published Date: 27 October 2021

Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features

Murtha-Lemekhova A, Fuchs J, Schulz E, Sterkenburg AS, Mayer P, Pfeiffenberger J, Hoffmann K

Journal of Hepatocellular Carcinoma 2021, 8:1269-1279

Published Date: 22 October 2021

Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia

Wang X, Liu X, Wang P, Yu L, Yan F, Yan H, Zhou D, Yang Z

Journal of Hepatocellular Carcinoma 2021, 8:1253-1267

Published Date: 21 October 2021

Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Wu JY, Yin ZY, Bai YN, Chen YF, Zhou SQ, Wang SJ, Zhou JY, Li YN, Qiu FN, Li B, Yan ML

Journal of Hepatocellular Carcinoma 2021, 8:1233-1240

Published Date: 5 October 2021

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma

Gok Yavuz B, Hasanov E, Lee SS, Mohamed YI, Curran MA, Koay EJ, Cristini V, Kaseb AO

Journal of Hepatocellular Carcinoma 2021, 8:1195-1207

Published Date: 24 September 2021

Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies

Huber TC, Bochnakova T, Koethe Y, Park B, Farsad K

Journal of Hepatocellular Carcinoma 2021, 8:1181-1193

Published Date: 23 September 2021

Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma

Abousaida B, Seneviratne D, Hoppe BS, Ko SJ, Asaithamby A, Cucinotta FA, Kirwan JM, Mody K, Toskich B, Ashman JB, Hallemeier CL, Krishnan S

Journal of Hepatocellular Carcinoma 2021, 8:1169-1179

Published Date: 24 September 2021

Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study

Gandhi M, Ling WH, Chen CH, Lee JH, Kudo M, Chanwat R, Strasser SI, Xu Z, Lai SH, Chow PKH

Journal of Hepatocellular Carcinoma 2021, 8:1159-1167

Published Date: 23 September 2021

A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma

Kaseb AO, Kappadath SC, Lee SS, Raghav KP, Mohamed YI, Xiao L, Morris JS, Ohaji C, Avritscher R, Odisio BC, Kuban J, Abdelsalam ME, Chasen B, Elsayes KM, Elbanan M, Wolff RA, Yao JC, Mahvash A

Journal of Hepatocellular Carcinoma 2021, 8:1129-1145

Published Date: 9 September 2021

Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review

Ji W, Xing Y, Ma J, Zhao Z, Xu H, Zheng S, Li W, Li X

Journal of Hepatocellular Carcinoma 2021, 8:1117-1127

Published Date: 7 September 2021

Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma

Fu S, Pan M, Zhang J, Zhang H, Tang Z, Li Y, Mu W, Huang J, Dong D, Duan C, Li X, Wang S, Chen X, He X, Yan J, Lu L, Tian J

Journal of Hepatocellular Carcinoma 2021, 8:1065-1076

Published Date: 4 September 2021

A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis

Mai H, Xie H, Hou J, Chen H, Zhou B, Hou J, Jiang D

Journal of Hepatocellular Carcinoma 2021, 8:1055-1064

Published Date: 2 September 2021

Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances

Charneau J, Suzuki T, Shimomura M, Fujinami N, Nakatsura T

Journal of Hepatocellular Carcinoma 2021, 8:1035-1054

Published Date: 2 September 2021

Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases

Chen JG, Zhu J, Zhang YH, Chen YS, Ding LL, Chen HZ, Shen AG, Wang GR

Journal of Hepatocellular Carcinoma 2021, 8:1023-1034

Published Date: 31 August 2021

Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma

Dai T, Ye L, Yu H, Li K, Li J, Liu R, Lu X, Deng M, Li R, Liu W, Yang Y, Wang G

Journal of Hepatocellular Carcinoma 2021, 8:997-1021

Published Date: 30 August 2021

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma

Liao H, Shi J, Wen K, Lin J, Liu Q, Shi B, Yan Y, Xiao Z

Journal of Hepatocellular Carcinoma 2021, 8:985-996

Published Date: 24 August 2021

Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis

Liu CM, Huang BS, Yen YH, Wang YM, Huang EY, Hsu HC, Huang TT, Yang YH, Cheng JY

Journal of Hepatocellular Carcinoma 2021, 8:963-973

Published Date: 18 August 2021

Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese

Mai H, Chen J, Chen H, Liu Z, Huang G, Wang J, Xiao Q, Ren W, Zhou B, Hou J, Jiang D

Journal of Hepatocellular Carcinoma 2021, 8:951-961

Published Date: 16 August 2021

Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis

Kilany S, Ata L, Gomaa A, Sabry A, Nada A, Tharwa ES, Badra G, Abogabal A, Elwaraky M, Moaz E, Ezzat S, Elsharawy A, Waked I

Journal of Hepatocellular Carcinoma 2021, 8:925-935

Published Date: 12 August 2021

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection

Ji GW, Fan Y, Sun DW, Wu MY, Wang K, Li XC, Wang XH

Journal of Hepatocellular Carcinoma 2021, 8:913-923

Published Date: 10 August 2021

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma

Ma Z, Li Z, Wang S, Zhou Q, Ma Z, Liu C, Huang B, Zheng Z, Yang L, Zou Y, Zhang C, Huang S, Hou B

Journal of Hepatocellular Carcinoma 2021, 8:899-912

Published Date: 7 August 2021

PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects

D'Alessio A, Rimassa L, Cortellini A, Pinato DJ

Journal of Hepatocellular Carcinoma 2021, 8:887-897

Published Date: 5 August 2021

DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma

Guo Y, Luo W, Huang S, Zhao W, Chen H, Ma Y, Ye M, Nie Y, Zhang Y, Huang C, Zhou Q, He X, Chen M

Journal of Hepatocellular Carcinoma 2021, 8:871-885

Published Date: 3 August 2021

Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated

De la Garza-Ramos C, Overfield CJ, Montazeri SA, Liou H, Paz-Fumagalli R, Frey GT, McKinney JM, Ritchie CA, Devcic Z, Lewis AR, Harnois DM, Patel T, Toskich BB

Journal of Hepatocellular Carcinoma 2021, 8:861-870

Published Date: 30 July 2021

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study

Yang Y, Zhou Y, Zhang X, Xin Y, Chen Y, Fan Q, Li X, Wei X, Li Q, Zhou X, Zhou J

Journal of Hepatocellular Carcinoma 2021, 8:837-850

Published Date: 28 July 2021

DNA and RNA Sequencing Recapitulated Aberrant Tumor Metabolism in Liver Cancer Cell Lines

Sun Y, Tang X, Ye B, Ding K

Journal of Hepatocellular Carcinoma 2021, 8:823-836

Published Date: 27 July 2021

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma

Shen YC, Lee PC, Kuo YL, Wu WK, Chen CC, Lei CH, Yeh CP, Hsu C, Hsu CH, Lin ZZ, Shao YY, Lu LC, Liu TH, Chen CH, Wu MS, Huang YH, Cheng AL

Journal of Hepatocellular Carcinoma 2021, 8:809-822

Published Date: 24 July 2021

Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging

Chen Y, Chen J, Zhang Y, Lin Z, Wang M, Huang L, Huang M, Tang M, Zhou X, Peng Z, Huang B, Feng ST

Journal of Hepatocellular Carcinoma 2021, 8:795-808

Published Date: 22 July 2021

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway

Song Y, Li Z, Li L, Zhou H, Zeng TT, Jin C, Lin JR, Gao S, Li Y, Guan XY, Zhu YH

Journal of Hepatocellular Carcinoma 2021, 8:759-771

Published Date: 6 July 2021

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions

Fornari F, Giovannini C, Piscaglia F, Gramantieri L

Journal of Hepatocellular Carcinoma 2021, 8:741-757

Published Date: 2 July 2021

Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma

Ismail MS, Mohamed I, Polychronopoulou E, Goss JA, Kuo YF, Kanwal F, Jalal PK

Journal of Hepatocellular Carcinoma 2021, 8:701-711

Published Date: 29 June 2021

Inhibition of SIRT1 Limits Self-Renewal and Oncogenesis by Inducing Senescence of Liver Cancer Stem Cells

Wang MJ, Chen JJ, Song SH, Su J, Zhao LH, Liu QG, Yang T, Chen Z, Liu C, Fu ZR, Hu YP, Chen F

Journal of Hepatocellular Carcinoma 2021, 8:685-699

Published Date: 29 June 2021

A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI

Sheng R, Huang J, Zhang W, Jin K, Yang L, Chong H, Fan J, Zhou J, Wu D, Zeng M

Journal of Hepatocellular Carcinoma 2021, 8:671-683

Published Date: 29 June 2021

Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients

Pan YX, Sun XQ, Hu ZL, Xie W, Nie KX, Fang AP, Zhang YY, Fu YZ, Chen JB, Wang JC, Wang X, Zhang YJ, Hu DD, Chen MS

Journal of Hepatocellular Carcinoma 2021, 8:657-670

Published Date: 25 June 2021

An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice

Lin BQ, Zhang WB, Zhao J, Zhou XH, Li YJ, Deng J, Zhao Q, Fu G, Xie CM, Xu YK, Feng GK

Journal of Hepatocellular Carcinoma 2021, 8:645-656

Published Date: 24 June 2021

Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria

Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X, Ouyang J, Li Q, Zhou J

Journal of Hepatocellular Carcinoma 2021, 8:625-644

Published Date: 21 June 2021

Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study

Cho YY, Yu SJ, Lee HW, Kim DY, Kang W, Paik YH, Sung PS, Bae SH, Park SC, Doh YS, Kim KM, Jang ES, Kim IH, Kim W, Kim YJ

Journal of Hepatocellular Carcinoma 2021, 8:613-623

Published Date: 18 June 2021

Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Chung SW, Park MK, Cho YY, Park Y, Lee CH, Oh H, Jang H, Kim MA, Kim SW, Nam JY, Lee YB, Cho EJ, Yu SJ, Kim HC, Kim YJ, Chung JW, Yoon JH, Lee JH

Journal of Hepatocellular Carcinoma 2021, 8:587-598

Published Date: 15 June 2021

Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center

Karbeyaz F, Kissling S, Jaklin PJ, Bachofner J, Brunner B, Müllhaupt B, Winder T, Mertens JC, Misselwitz B, von Felten S, Siebenhüner AR

Journal of Hepatocellular Carcinoma 2021, 8:565-574

Published Date: 11 June 2021

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma

Zhou Z, Lin L, An Y, Zhan M, Chen Y, Cai M, Zhu X, Lu L, Zhu K

Journal of Hepatocellular Carcinoma 2021, 8:529-543

Published Date: 8 June 2021

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma

Moura Cunha G, Chernyak V, Fowler KJ, Sirlin CB

Journal of Hepatocellular Carcinoma 2021, 8:513-527

Published Date: 31 May 2021

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

Monge C, Xie C, Steinberg SM, Greten TF

Journal of Hepatocellular Carcinoma 2021, 8:507-512

Published Date: 31 May 2021

Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications

Duan JL, Nie RC, Xiang ZC, Chen JW, Deng MH, Liang H, Wang FW, Luo RZ, Xie D, Cai MY

Journal of Hepatocellular Carcinoma 2021, 8:493-505

Published Date: 28 May 2021

Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC

Granito A, Marinelli S, Forgione A, Renzulli M, Benevento F, Piscaglia F, Tovoli F

Journal of Hepatocellular Carcinoma 2021, 8:477-492

Published Date: 26 May 2021

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B

Lee HW, Lee HW, Lee JS, Roh YH, Lee H, Kim SU, Park JY, Kim DY, Ahn SH, Kim BK

Journal of Hepatocellular Carcinoma 2021, 8:467-476

Published Date: 25 May 2021

The Mechanisms of HBV-Induced Hepatocellular Carcinoma

Jiang Y, Han Q, Zhao H, Zhang J

Journal of Hepatocellular Carcinoma 2021, 8:435-450

Published Date: 20 May 2021

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma

Abi-Jaoudeh N, Dayyani F, Chen PJ, Fernando D, Fidelman N, Javan H, Liang PC, Hwang JI, Imagawa DK

Journal of Hepatocellular Carcinoma 2021, 8:421-434

Published Date: 17 May 2021

Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide

Müller L, Stoehr F, Mähringer-Kunz A, Hahn F, Weinmann A, Kloeckner R

Journal of Hepatocellular Carcinoma 2021, 8:403-419

Published Date: 13 May 2021

Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options

Koulouris A, Tsagkaris C, Spyrou V, Pappa E, Troullinou A, Nikolaou M

Journal of Hepatocellular Carcinoma 2021, 8:387-401

Published Date: 13 May 2021

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma

Gramantieri L, Giovannini C, Piscaglia F, Fornari F

Journal of Hepatocellular Carcinoma 2021, 8:369-385

Published Date: 12 May 2021

Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency Ablation

Salman A, Salman M, Moustafa A, Shaaban HE, El-Mikkawy A, Labib S, Youssef A, Omar MG, Matter M, Elkassar H

Journal of Hepatocellular Carcinoma 2021, 8:313-320

Published Date: 29 April 2021

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma

Zhong Y, Yang Y, He L, Zhou Y, Cheng N, Chen G, Zhao B, Wang Y, Wang G, Liu X

Journal of Hepatocellular Carcinoma 2021, 8:301-312

Published Date: 29 April 2021

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection

Ye F, Huang W, Xue Y, Tang E, Wang M, Shi F, Wei D, Han Y, Chen P, Zhang X, Yu D

Journal of Hepatocellular Carcinoma 2021, 8:285-300

Published Date: 27 April 2021

ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway

Liu G, Li J, Zhang CY, Huang DY, Xu JW

Journal of Hepatocellular Carcinoma 2021, 8:271-284

Published Date: 21 April 2021

Ultrasound-Guided Percutaneous Ethanol-Paclitaxel Combined Therapy for Rabbit VX2 Liver Tumors

Chen L, Liu ZX, Bi QC, Zhao J, Liang QR, Tang Q

Journal of Hepatocellular Carcinoma 2021, 8:263-270

Published Date: 20 April 2021

NAFLD-Associated HCC: Progress and Opportunities

Geh D, Anstee QM, Reeves HL

Journal of Hepatocellular Carcinoma 2021, 8:223-239

Published Date: 8 April 2021

High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma

Guo X, Tian S, Cao P, Xie Y, Dong W

Journal of Hepatocellular Carcinoma 2021, 8:211-222

Published Date: 6 April 2021

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

Weng J, Zhou C, Zhou Q, Chen W, Yin Y, Atyah M, Dong Q, Shi Y, Ren N

Journal of Hepatocellular Carcinoma 2021, 8:193-209

Published Date: 29 March 2021

The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges

D'Alessio A, Prete MG, Cammarota A, Personeni N, Rimassa L

Journal of Hepatocellular Carcinoma 2021, 8:177-191

Published Date: 29 March 2021

Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

Mei J, Li SH, Li QJ, Sun XQ, Lu LH, Lin WP, Zheng L, Chen MS, Shi M, Wei W, Guo RP

Journal of Hepatocellular Carcinoma 2021, 8:167-176

Published Date: 25 March 2021

Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections

Gül-Klein S, Kästner A, Haber PK, Krenzien F, Wabitsch S, Krannich A, Andreou A, Eurich D, Tacke F, Horst D, Pratschke J, Schmelzle M

Journal of Hepatocellular Carcinoma 2021, 8:133-143

Published Date: 18 March 2021

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma

Wang Z, Embaye KS, Yang Q, Qin L, Zhang C, Liu L, Zhan X, Zhang F, Wang X, Qin S

Journal of Hepatocellular Carcinoma 2021, 8:119-132

Published Date: 16 March 2021

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)

Liang L, Wang MD, Zhang YM, Zhang WG, Zhang CW, Lau WY, Shen F, Pawlik TM, Huang DS, Yang T

Journal of Hepatocellular Carcinoma 2021, 8:103-118

Published Date: 12 March 2021

Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma

Chang X, Lv YF, He J, Cao Y, Li CQ, Guo QN

Journal of Hepatocellular Carcinoma 2021, 8:85-101

Published Date: 12 March 2021

Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model

Mauda-Havakuk M, Mikhail AS, Starost MF, Jones EC, Karim B, Kleiner DE, Partanen A, Esparza-Trujillo JA, Bakhutashvili I, Wakim PG, Kassin MT, Lewis AL, Karanian JW, Wood BJ, Pritchard WF

Journal of Hepatocellular Carcinoma 2021, 8:71-83

Published Date: 9 March 2021

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ

Journal of Hepatocellular Carcinoma 2021, 8:57-69

Published Date: 3 March 2021

Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes

Shi T, Kobara H, Oura K, Masaki T

Journal of Hepatocellular Carcinoma 2021, 8:45-55

Published Date: 11 February 2021

Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma

Ely A, Bloom K, Maepa MB, Arbuthnot P

Journal of Hepatocellular Carcinoma 2021, 8:1-17

Published Date: 27 January 2021

Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion

Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, Galle PR

Journal of Hepatocellular Carcinoma 2020, 7:423-433

Published Date: 21 December 2020

Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma

Zong J, Fan Z, Zhang Y

Journal of Hepatocellular Carcinoma 2020, 7:413-422

Published Date: 18 December 2020

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK

Journal of Hepatocellular Carcinoma 2020, 7:403-412

Published Date: 17 December 2020

Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant

Teng CF, Li TC, Wang T, Wu TH, Wang J, Wu HC, Shyu WC, Su IJ, Jeng LB

Journal of Hepatocellular Carcinoma 2020, 7:385-401

Published Date: 17 December 2020

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Sun X, Hu D, Zhang Y, Lyu N, Xu L, Chen Q, Lai J, Chen M, Zhao M

Journal of Hepatocellular Carcinoma 2020, 7:377-384

Published Date: 16 December 2020

Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma

Li M, Hu J, Jin R, Cheng H, Chen H, Li L, Guo K

Journal of Hepatocellular Carcinoma 2020, 7:361-376

Published Date: 8 December 2020

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y

Journal of Hepatocellular Carcinoma 2020, 7:337-345

Published Date: 1 December 2020

Value of Follow-Up Chest Computed Tomography in the Surveillance of Patients with Hepatocellular Carcinoma

Moawad AW, Elsayes KM, Benamar F, Rao K, Sun J, Szklaruk J

Journal of Hepatocellular Carcinoma 2020, 7:331-335

Published Date: 18 November 2020

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients

Jensen C, Holm Nielsen S, Eslam M, Genovese F, Nielsen MJ, Vongsuvanh R, Uchila R, van der Poorten D, George J, Karsdal MA, Leeming DJ, Willumsen N

Journal of Hepatocellular Carcinoma 2020, 7:301-313

Published Date: 9 November 2020

Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors

Chen S, Huang Z, Jia W, Tao H, Zhang S, Ma J, Liu Z, Wang J, Wang L, Cui P, Zhang Z, Huang D, Wu Z, Zheng X, Hu Y

Journal of Hepatocellular Carcinoma 2020, 7:289-299

Published Date: 2 November 2020

Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma

Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C

Journal of Hepatocellular Carcinoma 2020, 7:271-288

Published Date: 29 October 2020

miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation

Tang J, Xiao XQ, Jiang Y, Tian Y, Peng Z, Yang M, Xu Z, Gong G

Journal of Hepatocellular Carcinoma 2020, 7:257-269

Published Date: 29 October 2020

Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients

Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, Niu J

Journal of Hepatocellular Carcinoma 2020, 7:219-232

Published Date: 23 October 2020

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization

Kobayashi S, Tajiri K, Murayama A, Entani T, Futsukaichi Y, Nagata K, Takahashi K, Yasuda I

Journal of Hepatocellular Carcinoma 2020, 7:181-189

Published Date: 14 October 2020

Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization

Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN

Journal of Hepatocellular Carcinoma 2020, 7:155-158

Published Date: 28 September 2020

Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study

Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO

Journal of Hepatocellular Carcinoma 2020, 7:143-153

Published Date: 16 September 2020

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC

Journal of Hepatocellular Carcinoma 2020, 7:117-131

Published Date: 14 September 2020

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes

Campani C, Bensi C, Milani S, Galli A, Tarocchi M

Journal of Hepatocellular Carcinoma 2020, 7:107-116

Published Date: 30 July 2020

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging

Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM

Journal of Hepatocellular Carcinoma 2020, 7:77-89

Published Date: 23 April 2020

Rare Site Hepatocellular Carcinoma Metastasis

Boldo E, Santafe A, Mayol A, Lozoya R, Coret A, Escribano D, Fortea-Sanchis C, Muñoz A, Pastor JC, Perez de Lucia G, Bosch N

Journal of Hepatocellular Carcinoma 2020, 7:39-44

Published Date: 25 March 2020

Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2

Liu T, Li S, Wu L, Yu Q, Li J, Feng J, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C

Journal of Hepatocellular Carcinoma 2020, 7:19-31

Published Date: 18 February 2020

Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction

Dumenci OE, U AMR, Khan SA, Holmes E, Taylor-Robinson SD

Journal of Hepatocellular Carcinoma 2020, 7:1-9

Published Date: 7 January 2020

Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida

Jones PD, Scheinberg AR, Muenyi V, Gonzalez-Diaz J, Martin PM, Kobetz E

Journal of Hepatocellular Carcinoma 2019, 6:167-181

Published Date: 15 November 2019

Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine

Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T, Liu M, Han J, Li Z, Chen S

Journal of Hepatocellular Carcinoma 2019, 6:151-166

Published Date: 18 October 2019

Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma

Zakka K, Jiang R, Alese OB, Shaib WL, Wu C, Wedd JP, Sellers MT, Behera M, El-Rayes BF, Akce M

Journal of Hepatocellular Carcinoma 2019, 6:119-129

Published Date: 22 July 2019

Intermediate stage hepatocellular carcinoma: a summary review

Elshaarawy O, Gomaa A, Omar H, Rewisha E, Waked I

Journal of Hepatocellular Carcinoma 2019, 6:105-117

Published Date: 11 July 2019

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK

Journal of Hepatocellular Carcinoma 2019, 6:93-103

Published Date: 17 June 2019

Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma

Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML

Journal of Hepatocellular Carcinoma 2019, 6:85-91

Published Date: 6 June 2019

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB

Journal of Hepatocellular Carcinoma 2019, 6:49-69

Published Date: 5 February 2019

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach

Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK

Journal of Hepatocellular Carcinoma 2019, 6:41-48

Published Date: 31 January 2019

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date

Personeni N, Pressiani T, Rimassa L

Journal of Hepatocellular Carcinoma 2019, 6:31-39

Published Date: 31 January 2019

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M

Journal of Hepatocellular Carcinoma 2019, 6:1-10

Published Date: 21 December 2018

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I

Journal of Hepatocellular Carcinoma 2018, 5:109-119

Published Date: 19 November 2018

Hepatocellular cancer pain: impact and management challenges

Christian-Miller N, Frenette C

Journal of Hepatocellular Carcinoma 2018, 5:75-80

Published Date: 19 July 2018

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM

Journal of Hepatocellular Carcinoma 2018, 5:61-73

Published Date: 27 June 2018

Basic MRI for the liver oncologists and surgeons

Vu LN, Morelli JN, Szklaruk J

Journal of Hepatocellular Carcinoma 2018, 5:37-50

Published Date: 10 April 2018

Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

Shaker MK, Montasser IF, Sakr M, Elgharib M, Dabbous HM, Ebada H, El Dorry A, Bahaa M, El Meteini M

Journal of Hepatocellular Carcinoma 2018, 5:29-36

Published Date: 27 February 2018

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma

Najjar M, Agrawal S, Emond JC, Halazun KJ

Journal of Hepatocellular Carcinoma 2018, 5:17-28

Published Date: 18 January 2018

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N

Journal of Hepatocellular Carcinoma 2018, 5:9-15

Published Date: 12 January 2018

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

Liang B, Yao SY, Zhou JP, Li ZK, Liu TQ

Journal of Hepatocellular Carcinoma 2018, 5:1-7

Published Date: 12 January 2018

Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator

Suryatenggara J, Wibowo H, Atmodjo WL, Mathew G

Journal of Hepatocellular Carcinoma 2017, 4:139-151

Published Date: 28 November 2017

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

Fateen W, Khan F, O’Neill RJ, James MW, Ryder SD, Aithal GP

Journal of Hepatocellular Carcinoma 2017, 4:123-130

Published Date: 16 October 2017

A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

de la Torre AN, Contractor S, Castaneda I, Cathcart CS, Razdan D, Klyde D, Kisza P, Gonzales SF, Salazar AM

Journal of Hepatocellular Carcinoma 2017, 4:111-121

Published Date: 7 August 2017

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review

Sacco R, Tapete G, Simonetti N, Sellitri R, Natali V, Melissari S, Cabibbo G, Biscaglia L, Bresci G, Giacomelli L

Journal of Hepatocellular Carcinoma 2017, 4:105-110

Published Date: 27 July 2017

Hepatocellular carcinoma: early-stage management challenges

Erstad DJ, Tanabe KK

Journal of Hepatocellular Carcinoma 2017, 4:81-92

Published Date: 23 June 2017

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Tarakanovskaya MG, Chinburen J, Batchuluun P, Munkhzaya C, Purevsuren G, Dandii D, Hulan T, Oyungerel D, Kutsyna GA, Reid AA, Borisova V, Bain AI, Jirathitikal V, Bourinbaiar AS

Journal of Hepatocellular Carcinoma 2017, 4:59-69

Published Date: 12 April 2017

A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus

Chotirosniramit A, Liwattanakun A, Lapisatepun W, Ko-iam W, Sandhu T, Junrungsee S

Journal of Hepatocellular Carcinoma 2017, 4:41-47

Published Date: 7 March 2017

Liver Imaging Reporting and Data System: an expert consensus statement

Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB

Journal of Hepatocellular Carcinoma 2017, 4:29-39

Published Date: 17 February 2017

Pediatric hepatocellular carcinoma: challenges and solutions

Schmid I, von Schweinitz D

Journal of Hepatocellular Carcinoma 2017, 4:15-21

Published Date: 16 January 2017

GPC-3 in hepatocellular carcinoma: current perspectives

Wu Y, Liu H, Ding H

Journal of Hepatocellular Carcinoma 2016, 3:63-67

Published Date: 8 November 2016

Minimally invasive image-guided therapies for hepatocellular carcinoma

Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC

Journal of Hepatocellular Carcinoma 2016, 3:55-61

Published Date: 11 October 2016

Hepatocellular carcinoma: a review

Balogh J, Victor III D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour Jr HP

Journal of Hepatocellular Carcinoma 2016, 3:41-53

Published Date: 5 October 2016

Transarterial radioembolization for hepatocellular carcinoma: a review

Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S, Eggenhoffner R, Bresci G, Cabibbo G, Giacomelli L

Journal of Hepatocellular Carcinoma 2016, 3:25-29

Published Date: 25 July 2016

Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients

Atta MM, Atta HM, Gad MA, Rashed LA, Said EM, Hassanien SE, Kaseb AO

Journal of Hepatocellular Carcinoma 2016, 3:19-24

Published Date: 14 June 2016

Hepatocellular carcinoma in elderly patients: challenges and solutions

Brunot A, Le Sourd S, Pracht M, Edeline J

Journal of Hepatocellular Carcinoma 2016, 3:9-18

Published Date: 17 June 2016

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO

Journal of Hepatocellular Carcinoma 2016, 3:1-7

Published Date: 5 February 2016

Fibrolamellar hepatocellular carcinoma: current clinical perspectives

Lafaro KJ, Pawlik TM

Journal of Hepatocellular Carcinoma 2015, 2:151-157

Published Date: 9 October 2015

Role of endoscopic ultrasound in diagnosis and management of hepatocellular carcinoma

Koduru P, Suzuki R, Lakhtakia S, Ramchandani M, Makmun D, Bhutani MS

Journal of Hepatocellular Carcinoma 2015, 2:143-149

Published Date: 6 October 2015

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO

Journal of Hepatocellular Carcinoma 2015, 2:131-142

Published Date: 18 September 2015

Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P

Journal of Hepatocellular Carcinoma 2015, 2:79-89

Published Date: 22 June 2015

Emerging role of Hpo signaling and YAP in hepatocellular carcinoma

Valero V III, Pawlik TM, Anders RA

Journal of Hepatocellular Carcinoma 2015, 2:69-78

Published Date: 18 June 2015

Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy

Gao F, Jing P, Liu J, Lu YF, Zhang PC, Han W, Liu GL, Ru N, Cui GH, Sun CL, Che YB, Zhang HM, Hu QL, Wang HY, Wu YL, Guan CJ, Fu Q, Ma ZL, Yu BF

Journal of Hepatocellular Carcinoma 2015, 2:57-68

Published Date: 9 June 2015

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib

Lee SH, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH

Journal of Hepatocellular Carcinoma 2015, 2:39-47

Published Date: 28 April 2015

c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

Granito A, Guidetti E, Gramantieri L

Journal of Hepatocellular Carcinoma 2015, 2:29-38

Published Date: 24 April 2015

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma

Yang J, Li M, Zheng QC

Journal of Hepatocellular Carcinoma 2015, 2:11-17

Published Date: 16 February 2015

Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors

Zeeneldin AA, Salem SE, Darwish AD, El-Gammal MM, Hussein MM, Saadeldin M

Journal of Hepatocellular Carcinoma 2015, 2:3-9

Published Date: 30 January 2015

Welcome to Journal of Hepatocellular Carcinoma

Kaseb AO

Journal of Hepatocellular Carcinoma 2015, 2:1-2

Published Date: 9 January 2015

Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy

Bishay VL, Maglione K, Khanna R, Lee KM, Fischman AM, Lookstein RA, Kim E

Journal of Hepatocellular Carcinoma 2014, 1:187-193

Published Date: 27 November 2014

Radiological diagnosis of hepatocellular carcinoma

Bargellini I, Battaglia V, Bozzi E, Lauretti DL, Lorenzoni G, Bartolozzi C

Journal of Hepatocellular Carcinoma 2014, 1:137-148

Published Date: 9 September 2014

Clinical utility of imaging for evaluation of hepatocellular carcinoma

Murakami T, Tsurusaki M, Hyodo T, Imai Y

Journal of Hepatocellular Carcinoma 2014, 1:101-108

Published Date: 14 July 2014

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives

Hsu CH, Shen YC, Shao YY, Hsu C, Cheng AL

Journal of Hepatocellular Carcinoma 2014, 1:85-99

Published Date: 12 June 2014

New insights on the role of epigenetic alterations in hepatocellular carcinoma

Frau M, Feo CF, Feo F, Pascale RM

Journal of Hepatocellular Carcinoma 2014, 1:65-83

Published Date: 12 June 2014

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma

Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA

Journal of Hepatocellular Carcinoma 2014, 1:55-63

Published Date: 9 June 2014

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma

Ofuji K, Saito K, Yoshikawa T, Nakatsura T

Journal of Hepatocellular Carcinoma 2014, 1:35-42

Published Date: 21 May 2014

Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma

Akiel M, Rajasekaran D, Gredler R, Siddiq A, Srivastava J, Robertson C, Jariwala NH, Fisher PB, Sarkar D

Journal of Hepatocellular Carcinoma 2014, 1:9-19

Published Date: 26 March 2014